SCHEMBL25826368

SCHEMBL25826368

Cc1cc(Cc2cnc3[nH]c(-c4ccc(Nc5ccnc6ccc(N(C)C)cc56)cc4)nc3c2)ccn1

nearest known ligand 0.43

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 11/20 0.43
▸ MAPKAPK2 P49137 8/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25826379 0.90 KDR (0.35) KDRMAPKAPK2
SCHEMBL23999610 0.85 KDR (0.47) KDRMAPKAPK2
SCHEMBL30180419 0.85 KDR (0.47) KDRMAPKAPK2
SCHEMBL25826446 0.82 KDR (0.46) KDRMAPKAPK2
SCHEMBL26310194 0.81 KDR (0.41) KDRMAPKAPK2
SCHEMBL30180450 0.78 KDR (0.53) KDRMAPKAPK2
SCHEMBL23999675 0.78 KDR (0.53) KDRMAPKAPK2
SCHEMBL23999659 0.78 L3MBTL1 (0.43) KDR
SCHEMBL23999830 0.77 KDR (0.44) KDRMAPKAPK2
SCHEMBL30180305 0.77 KDR (0.40) KDRMAPKAPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183226-A1 AKT3 MODULATORS AKT3, AKT2, MTOR KDR 3271/4885MAPKAPK2 138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback